Wan‐Hsin Liu

932 total citations
31 papers, 693 citations indexed

About

Wan‐Hsin Liu is a scholar working on Molecular Biology, Economics and Econometrics and Cancer Research. According to data from OpenAlex, Wan‐Hsin Liu has authored 31 papers receiving a total of 693 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 7 papers in Economics and Econometrics and 7 papers in Cancer Research. Recurrent topics in Wan‐Hsin Liu's work include Global trade and economics (5 papers), MicroRNA in disease regulation (4 papers) and International Business and FDI (4 papers). Wan‐Hsin Liu is often cited by papers focused on Global trade and economics (5 papers), MicroRNA in disease regulation (4 papers) and International Business and FDI (4 papers). Wan‐Hsin Liu collaborates with scholars based in Germany, Taiwan and Italy. Wan‐Hsin Liu's co-authors include Pei‐Jer Chen, Shiou‐Hwei Yeh, Ding‐Shinn Chen, Chien‐Yu Lin, Sung‐Liang Yu, Frank Bickenbach, Chi‐Ling Chen, Peter Nunnenkamp, Po‐Jen Chen and Hsuan‐Cheng Huang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Gastroenterology and PLoS ONE.

In The Last Decade

Wan‐Hsin Liu

29 papers receiving 680 citations

Peers

Wan‐Hsin Liu
Rui Fan China
Yong Guo China
Samantha Thompson United States
Mark Stewart United States
Michael Cuddy United States
Rui Fan China
Wan‐Hsin Liu
Citations per year, relative to Wan‐Hsin Liu Wan‐Hsin Liu (= 1×) peers Rui Fan

Countries citing papers authored by Wan‐Hsin Liu

Since Specialization
Citations

This map shows the geographic impact of Wan‐Hsin Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wan‐Hsin Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wan‐Hsin Liu more than expected).

Fields of papers citing papers by Wan‐Hsin Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wan‐Hsin Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wan‐Hsin Liu. The network helps show where Wan‐Hsin Liu may publish in the future.

Co-authorship network of co-authors of Wan‐Hsin Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Wan‐Hsin Liu. A scholar is included among the top collaborators of Wan‐Hsin Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wan‐Hsin Liu. Wan‐Hsin Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bickenbach, Frank & Wan‐Hsin Liu. (2024). Konjunkturschlaglicht: Widersprüche in Chinas neuer Wachstumsstrategie. Wirtschaftsdienst. 104(9). 655–656.
2.
Bickenbach, Frank, Dirk Dohse, Rolf J. Langhammer, & Wan‐Hsin Liu. (2024). EU Concerns About Chinese Subsidies: What the Evidence Suggests. Intereconomics. 59(4). 214–221. 3 indexed citations
3.
Bickenbach, Frank & Wan‐Hsin Liu. (2023). Wie China internen und externen wirtschaftlichen Herausforderungen begegnen will. Wirtschaftsdienst. 103(7). 484–490. 1 indexed citations
4.
Lin, Tzu‐Chieh, Yen-Ling Liu, Yuting Liu, et al.. (2022). TRIPBASE: a database for identifying the human genomic DNA and lncRNA triplexes. NAR Genomics and Bioinformatics. 5(2). lqad043–lqad043. 2 indexed citations
5.
Liu, Wan‐Hsin, et al.. (2022). Exploring kinase family inhibitors and their moiety preferences using deep SHapley additive exPlanations. BMC Bioinformatics. 23(S4). 242–242. 9 indexed citations
6.
Liu, Wan‐Hsin, et al.. (2021). China’s Investments in Germany and the Impact of the COVID-19 Pandemic. Intereconomics. 56(2). 113–119. 4 indexed citations
7.
Bickenbach, Frank, Wan‐Hsin Liu, & Peter Nunnenkamp. (2018). How global is FDI? Evidence from the analysis of Theil indices. Empirical Economics. 55(4). 1603–1635. 9 indexed citations
8.
Liu, Wan‐Hsin, Zing Tsung‐Yeh Tsai, & Huai‐Kuang Tsai. (2017). Comparative genomic analyses highlight the contribution of pseudogenized protein-coding genes to human lincRNAs. BMC Genomics. 18(1). 786–786. 15 indexed citations
9.
Bickenbach, Frank, Dirk Dohse, & Wan‐Hsin Liu. (2017). University Students' Entrepreneurial Intentions: A Comparative Analysis of Hong Kong and Guangzhou. China & World Economy. 25(2). 60–84. 10 indexed citations
10.
Lin, Yi‐Wen, Wan‐Hsin Liu, Yung‐Tsung Chen, et al.. (2015). Inactivated Enterovirus 71 Vaccine Produced by 200-L Scale Serum-Free Microcarrier Bioreactor System Provides Cross-Protective Efficacy in Human SCARB2 Transgenic Mouse. PLoS ONE. 10(8). e0136420–e0136420. 25 indexed citations
11.
Bickenbach, Frank, Wan‐Hsin Liu, & Peter Nunnenkamp. (2014). Regional concentration of FDI in post-reform India: A district-level analysis. Journal of International Trade & Economic Development. 24(5). 660–695. 10 indexed citations
12.
Liu, Wan‐Hsin. (2014). Relevance of Own R&D and Sources of Knowledge Transfer for Industrial Innovation in China. The Developing Economies. 52(1). 1–25. 3 indexed citations
13.
Bickenbach, Frank & Wan‐Hsin Liu. (2013). Regional Inequality of Higher Education in China and the Role of Unequal Economic Development. Frontiers of Education in China. 8(2). 266–302. 7 indexed citations
14.
Liu, Wan‐Hsin, Chao-Hung Chen, Kun‐Huei Yeh, et al.. (2013). ADAR2-Mediated Editing of miR-214 and miR-122 Precursor and Antisense RNA Transcripts in Liver Cancers. PLoS ONE. 8(12). e81922–e81922. 31 indexed citations
15.
Chen, Po‐Jen, Shiou‐Hwei Yeh, Wan‐Hsin Liu, et al.. (2012). Androgen pathway stimulates MicroRNA-216a transcription to suppress the tumor suppressor in lung cancer-1 gene in early hepatocarcinogenesis. Hepatology. 56(2). 632–643. 90 indexed citations
16.
Bickenbach, Frank & Wan‐Hsin Liu. (2012). Firm characteristics and informal governance of business operations in the Pearl River Delta, China. Zeitschrift für Wirtschaftsgeographie. 56(1-2). 25–42. 2 indexed citations
17.
Liu, Wan‐Hsin, Shiou‐Hwei Yeh, & Pei‐Jer Chen. (2011). Role of microRNAs in hepatitis B virus replication and pathogenesis. Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms. 1809(11-12). 678–685. 80 indexed citations
18.
Liu, Wan‐Hsin & Peter Nunnenkamp. (2010). Domestic Repercussions of Different Types of FDI: Firm-Level Evidence for Taiwanese Manufacturing. World Development. 39(5). 808–823. 13 indexed citations
19.
Liu, Wan‐Hsin, Shiou‐Hwei Yeh, Sung‐Liang Yu, et al.. (2008). MicroRNA-18a Prevents Estrogen Receptor-α Expression, Promoting Proliferation of Hepatocellular Carcinoma Cells. Gastroenterology. 136(2). 683–693. 224 indexed citations
20.
Liu, Wan‐Hsin, et al.. (2007). Characterization of novel transforming growth factor-beta type I receptors found in malignant pleural effusion tumor cells. BMC Molecular Biology. 8(1). 72–72. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026